Philippines Places Dengue Immunization Program On Hold In Light Of New Health Risk Findings From Manufacturer

Associated Press: Philippines puts dengue immunization program on hold
“The Philippines on Friday put on hold its dengue immunization program, the world’s first, after new findings by the vaccine manufacturer that severe cases of dengue can occur in the longer term among those vaccinated without prior infection…” (12/1).

CNN Philippines: Gov’t halts dengue vaccination program due to health risk
“…Those at risk are some 70,000 children who were vaccinated under a Health Department program since 2016. ‘In the light of this new analysis, the DOH will place the dengue vaccination program on hold while review and consultation are ongoing with experts and key stakeholders and the WHO (World Health Organization),’ Health Secretary Francisco Duque III said in a media briefing on Friday…” (Tan, 12/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.